Tetanus

178 Tetanus





Epidemiology


Tetanus is a rare disease in the United States, with only 20 cases reported in 2003. In 1990 to 2000, the average number of cases in the United States was 50 per year. The average annual incidence from 1995 to 2000 was approximately 0.16 cases per million population.1,2 Tetanus is more common among people 60 years old or older (0.35 cases per million population), patients 60 years old or older who have diabetes (0.70 cases per million population), and Hispanic persons (0.37 cases per million population). Injecting drug users are at unique risk for tetanus and accounted for 15% of cases of tetanus from 1998 to 2000.1 Most (74%) injecting drug users who developed tetanus reported injecting heroin, and 100% reported “skin popping” rather than intravenous injection.3


Tetanus morbidity and mortality remain high, even with appropriate treatment. Current vaccination status decreases the severity of the disease and the likelihood of death from tetanus. In 1998 to 2000, 18% of patients with tetanus died. Of fatal cases, 75% occurred in patients who were 60 years old or older. No patients with an up-to-date vaccination status died of tetanus.1



Perspective


Although clinical cases are rare, emergency physicians (EPs) often are the first, and sometimes only, point of contact for patients. As a result, physicians must maintain an awareness of the clinical presentation of the disease. The diagnosis can be suspected but not confirmed in the emergency department (ED).


In addition to recognizing the clinical presentation of tetanus, EPs play a vital role in the prevention of the disease. Primary pediatric vaccination and regular decennial booster vaccination are the mainstays of disease prevention and severity modulation.4 Herd immunity does not occur with tetanus. Therefore, only people who receive the vaccination benefit from immunization. In the United States, the prevalence of tetanus immunity decreases by age, after 40 years of age. At 40 years of age, 80% of the population is immune to tetanus. By the age of 80 years, only 30% of the population remains immune. This decrease is most striking in women and Mexican Americans.5 Only 36% of persons age 65 years old or older report receiving tetanus vaccination in the past 10 years.6,7 Most cases of tetanus and fatalities resulting from tetanus are in patients who either have never been vaccinated or have not had a booster in the past 10 years.8 EPs have the opportunity to provide booster vaccination at times of minor to severe injury and skin infection. In light of pertussis epidemics, providers should also consider a patient’s pertussis immunization status when choosing the tetanus vaccine.




Anatomy


Most cases of tetanus are associated with acute trauma (Table 178.1), but many cases are associated with abscesses, cellulitis, chronic ulcers, dental infections, frostbite, and gangrene. In one study of injecting drug users with tetanus, 69% had an abscess at the injection site.3 Tetanus affects postpartum women, with an increased risk after unsanitary birth or abortion practices.1


Table 178.1 Tetanus Wound Characteristics and Risks



















  MOST THREATENING MOST COMMON
Location of injury Face Lower extremity
Upper extremity
Head and trunk
Type of injury Puncture wound
Crush injury
Burn
Chronic ulcer
Puncture wound
Laceration
Chronic wound
Abrasion
Patients Diabetic patients
Age > 60 yr
Neonates
No prior tetanus immunization
Intravenous drug users
Age > 60 yr
Hispanic ethnicity
Diabetic patients
No prior tetanus immunization
Last immunization >10 yr ago

Puncture wounds are the most frequent type of acute trauma associated with tetanus. Puncture wounds include nail injuries to the foot, splinters, barbed wire injuries, tattoos, drug injection, penetrating eye injuries, and spider bites. Crush injuries, burns, and eye injuries are also portals of tetanus infection. In patients with tetanus, approximately 50% of injuries are located on the lower extremity, 36% on the upper extremity, 10% on the head or trunk, and 5% on other areas.1


The occurrence of tetanus following minor or trivial wounds is well documented in the literature. Tetanus results from minor wounds and abrasions when proper wound care is not administered.2,912 Nearly half of the wounds that resulted in tetanus in 1998 to 2000 occurred indoors.1



Pathophysiology


Clinical tetanus is caused by two exotoxins produced by Clostridium tetani, a gram-positive, anaerobic rod. The bacterium produces spores that are heat resistant, surviving autoclaving at 250° F for 10 to 15 minutes, and resistant to treatment with phenols and common chemical agents. The bacterium dies with heat or oxygen exposure. The bacterium and spores are widely disseminated in soil, intestines of farm animals and pets, and feces. Spores exist on human skin and contaminated heroin. In anaerobic conditions, such as puncture wounds and crush injuries, spores germinate.



C. tetani enters the body through a wound and produces two exotoxins: tetanolysin and tetanospasmin. Tetanolysin causes local cell death and creates an anaerobic environment in the wound site.13 Tetanospasmin interferes with the transmission of inhibitory impulses in the central nervous system. It creates a presynaptic blockage of the inhibitory Renshaw cells and Ia fibers of alpha motoneurons that transmit gamma-aminobutyric acid (GABA) and glycine. Renshaw cells that transmit acetylcholine are not affected as strongly. Tetanospasmin binding prevents inhibitory signals in the central nervous system.


Tetanus becomes a systemic disease as the toxin spreads through the body. Tetanospasmin binds to nerve terminals, is internalized, and travels in retrograde fashion to the cell synapse. The toxin travels at 75 to 250 mm/day, and it affects synapses of shorter nerves before synapses of longer nerves.14 The toxin also travels by lymphatic and blood flow to remote nerves. The toxin exhibits local effects first and then spinal motor effects. The autonomic system is the last to be affected because of the length of the nerves. Tetanospasmin also inhibits acetylcholine release, a process that leads to flaccid paralysis between episodes of spasticity.15


The result of the general loss of inhibitory signals is rigidity with periods of spasticity. The reflex inhibition of antagonizing muscles is lost, thus allowing agonist and antagonist muscle groups to contract simultaneously. Autonomic disinhibition occurs late in the disease. Toxin binding appears to be irreversible; the growth of new nerve terminals is required to overcome the effects.16



Clinical Presentation


The average incubation period from time of injury to the onset of symptoms is 7 to 10 days, with a range of 1 to 60 days. Shorter incubation times are associated with more severe clinical presentation and a poor prognosis.8,16 Tetanus is usually an afebrile disease until autonomic instability occurs late in the disease. Fever suggests coinfection of the wound or other infectious causes. Generalized tetanus, or tetanus affecting the whole body, is the most common form of tetanus.


In the first week of illness, the patient presents with rigidity and muscle spasms. Tetanus most commonly affects the cranial nerves first. The most common first symptoms and signs are trismus, neck stiffness, and dysphagia. Muscle spasm progresses diffusely to involve the facial muscles, thus causing the classic facial grimace risus sardonicus. Disinhibition of the neck muscles causes neck extension. Truncal rigidity follows head and neck involvement.


The general increased tone is interrupted by acute spastic events that can involve any muscle groups. These spastic events can be spontaneous or caused by tactile, visual, or auditory stimuli. Agonist and antagonist muscle groups can simultaneously contract. The contractions are painful and can be strong enough to break long bones and avulse tendons. Opisthotonos is a classic spastic event in tetanus. Abdominal rigidity can mimic an acute abdomen. Spasticity of the trunk and diaphragm can interfere with respiration. Laryngeal spasm interferes with the gag reflex or can occlude the airway.


Before modern mechanical ventilation, death resulted from respiratory failure or aspiration.17 With modern mechanical ventilation, death is more commonly caused by autonomic events.18,19

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 14, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on Tetanus

Full access? Get Clinical Tree

Get Clinical Tree app for offline access